The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Dapagliflozin versus empagliflozin in patients with chronic kidney disease
|
|---|---|
| Published in |
Frontiers in Pharmacology, August 2023
|
| DOI | 10.3389/fphar.2023.1227199 |
| Pubmed ID | |
| Authors |
Hilmi Alnsasra, Gal Tsaban, Adam Solomon, Fouad Khalil, Enis Aboalhasan, Abed N. Azab, Joseph Azuri, Ariel Hammerman, Ronen Arbel |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 17% |
| Unknown | 5 | 83% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 6 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 56 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 8 | 14% |
| Researcher | 5 | 9% |
| Student > Bachelor | 4 | 7% |
| Other | 3 | 5% |
| Unspecified | 2 | 4% |
| Other | 5 | 9% |
| Unknown | 29 | 52% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 9 | 16% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 9% |
| Biochemistry, Genetics and Molecular Biology | 3 | 5% |
| Unspecified | 2 | 4% |
| Nursing and Health Professions | 2 | 4% |
| Other | 3 | 5% |
| Unknown | 32 | 57% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 February 2024.
All research outputs
#15,056,886
of 25,600,774 outputs
Outputs from Frontiers in Pharmacology
#4,751
of 19,975 outputs
Outputs of similar age
#151,604
of 360,604 outputs
Outputs of similar age from Frontiers in Pharmacology
#95
of 690 outputs
Altmetric has tracked 25,600,774 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 19,975 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 360,604 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.
We're also able to compare this research output to 690 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.